As ETS TFs have been implicated in promoting tumor progression51, in part through transcriptional regulation of integrins and ECM remodeling components52, SIX1-mediated repression of ETS TF target genes, in concert with EWS/FLI1, could explain SIX1’s anti-metastatic role in this context. The gene discussed is SIX1; the disease is neoplasm.